Search Results

There are 22390 results for: content related to: Anti-TNF therapy is associated with decreased imaging and radiation exposure in patients with Crohn's disease

  1. You have free access to this content
    2015 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 67, Issue S10, October 2015, Pages: 1–4046,

    Version of Record online : 5 NOV 2015, DOI: 10.1002/art.39448

  2. You have free access to this content
    Systematic review: factors associated with relapse of inflammatory bowel disease after discontinuation of anti-TNF therapy

    Alimentary Pharmacology & Therapeutics

    Volume 42, Issue 4, August 2015, Pages: 391–405, J. P. Gisbert, A. C. Marín and M. Chaparro

    Version of Record online : 15 JUN 2015, DOI: 10.1111/apt.13276

  3. You have free access to this content
    ACR Meeting

    Arthritis & Rheumatism

    Volume 64, Issue S10, October 2012, Pages: S1–S1216,

    Version of Record online : 11 OCT 2012, DOI: 10.1002/art.37735

  4. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease

    Inflammatory Bowel Diseases

    Amit Desai, Zachary A. Zator, Punyanganie de Silva, Deanna D. Nguyen, Joshua Korzenik, Vijay Yajnik and Ashwin N. Ananthakrishnan

    Version of Record online : 17 MAY 2012, DOI: 10.1002/ibd.23026

  5. You have free access to this content
    Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 36, Issue 5, September 2012, Pages: 459–466, P. S. A. de Silva, D. D. Nguyen, J. Sauk, J. Korzenik, V. Yajnik and A. N. Ananthakrishnan

    Version of Record online : 11 JUL 2012, DOI: 10.1111/j.1365-2036.2012.05214.x

  6. You have free access to this content
    2016 ACR/ARHP Annual Meeting Abstract Supplement

    Arthritis & Rheumatology

    Volume 68, Issue S10, October 2016, Pages: 1–4550,

    Version of Record online : 8 NOV 2016, DOI: 10.1002/art.39977

  7. You have free access to this content
    Systematic review with network meta-analysis: the efficacy of anti-TNF agents for the treatment of Crohn's disease

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 12, June 2014, Pages: 1349–1362, R. W. Stidham, T. C. H. Lee, P. D. R. Higgins, A. R. Deshpande, D. A. Sussman, A. G. Singal, B. J. Elmunzer, S. D. Saini, S. Vijan and A. K. Waljee

    Version of Record online : 20 APR 2014, DOI: 10.1111/apt.12749

  8. You have free access to this content
    Use of a disease risk score to compare serious infections associated with anti–tumor necrosis factor therapy among high- versus lower-risk rheumatoid arthritis patients

    Arthritis Care & Research

    Volume 64, Issue 10, October 2012, Pages: 1480–1489, Jeffrey R. Curtis, Fenglong Xie, Lang Chen, Paul Muntner, Carlos G. Grijalva, Claire Spettell, Joaquim Fernandes, Raechele M. Mcmahan, John W. Baddley, Kenneth G. Saag, Timothy Beukelman and Elizabeth Delzell

    Version of Record online : 27 SEP 2012, DOI: 10.1002/acr.21805

  9. You have free access to this content
    When to use biological agents in inflammatory bowel disease

    Journal of Gastroenterology and Hepatology

    Volume 27, Issue 7, July 2012, Pages: 1141–1149, Crispin Corte, Payal Saxena, Stephen Tattersall, Christian Selinger and Rupert W Leong

    Version of Record online : 19 JUN 2012, DOI: 10.1111/j.1440-1746.2011.07056.x

  10. You have free access to this content
    Response to biologic therapy in Crohn's disease is improved with early treatment: An analysis of health claims data

    Inflammatory Bowel Diseases

    Volume 18, Issue 12, December 2012, Pages: 2225–2231, David T. Rubin, Ozgecan Uluscu and Robert Sederman

    Version of Record online : 22 FEB 2012, DOI: 10.1002/ibd.22925

  11. You have free access to this content
    Systematic review with network meta-analysis: the efficacy of anti-tumour necrosis factor-alpha agents for the treatment of ulcerative colitis

    Alimentary Pharmacology & Therapeutics

    Volume 39, Issue 7, April 2014, Pages: 660–671, R. W. Stidham, T. C. H. Lee, P. D. R. Higgins, A. R. Deshpande, D. A. Sussman, A. G. Singal, B. J. Elmunzer, S. D. Saini, S. Vijan and A. K. Waljee

    Version of Record online : 9 FEB 2014, DOI: 10.1111/apt.12644

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 39, Issue 11, 1345–1347, Version of Record online: 6 MAY 2014

    Corrected by:

    Corrigendum: Corrigendum

    Vol. 42, Issue 1, 130, Version of Record online: 4 JUN 2015

  12. You have full text access to this OnlineOpen article
    Rituximab or a second anti–tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti–tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register

    Arthritis Care & Research

    Volume 64, Issue 8, August 2012, Pages: 1108–1115, Moetaza M. Soliman, Kimme L. Hyrich, Mark Lunt, Kath D. Watson, Deborah P. M. Symmons, Darren M. Ashcroft and on behalf of the British Society for Rheumatology Biologics Register

    Version of Record online : 27 JUL 2012, DOI: 10.1002/acr.21663

  13. You have free access to this content
    Cancer risk in patients with rheumatoid arthritis treated with anti–tumor necrosis factor α therapies: Does the risk change with the time since start of treatment?

    Arthritis & Rheumatism

    Volume 60, Issue 11, November 2009, Pages: 3180–3189, Johan Askling, Ronald F. van Vollenhoven, Fredrik Granath, Pauline Raaschou, C. Michael Fored, Eva Baecklund, Christina Dackhammar, Nils Feltelius, Lars Cöster, Pierre Geborek, Lennart T. Jacobsson, Staffan Lindblad, Solbritt Rantapää-Dahlqvist, Tore Saxne and Lars Klareskog

    Version of Record online : 29 OCT 2009, DOI: 10.1002/art.24941

  14. You have free access to this content
    New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease

    Alimentary Pharmacology & Therapeutics

    Volume 41, Issue 10, May 2015, Pages: 972–979, E. Shelton, K. Chaudrey, J. Sauk, H. Khalili, R. Masia, D. D. Nguyen, V. Yajnik and A. N. Ananthakrishnan

    Version of Record online : 10 MAR 2015, DOI: 10.1111/apt.13159

  15. You have free access to this content
    The TTTT B lymphocyte stimulator promoter haplotype is associated with good response to rituximab therapy in seropositive rheumatoid arthritis resistant to tumor necrosis factor blockers

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 88–97, Martina Fabris, Luca Quartuccio, Ed Vital, Elena Pontarini, Sara Salvin, Cinzia Fabro, Alen Zabotti, Maurizio Benucci, Mariangela Manfredi, Viviana Ravagnani, Domenico Biasi, Fabiola Atzeni, Piercarlo Sarzi-Puttini, Pia Morassi, Fabio Fischetti, Laura Bazzicchi, Marta Saracco, Raffaele Pellerito, Marco Cimmino, Valeria Carraro, Angelo Semeraro, Franco Schiavon, Roberto Caporali, Roberto Bortolotti, Marcello Govoni, Federico Fogolari, Elio Tonutti, Stefano Bombardieri, Paul Emery and Salvatore De Vita

    Version of Record online : 27 DEC 2012, DOI: 10.1002/art.37707

  16. Efficacy and safety of adalimumab in patients with psoriasis previously treated with anti-tumour necrosis factor agents: subanalysis of BELIEVE

    Journal of the European Academy of Dermatology and Venereology

    Volume 25, Issue 9, September 2011, Pages: 1012–1020, J.-P. Ortonne, S. Chimenti, K. Reich, R. Gniadecki, P. Sprøgel, K. Unnebrink, H. Kupper, O. Goldblum and D. Thaçi

    Version of Record online : 9 JAN 2011, DOI: 10.1111/j.1468-3083.2010.03944.x

  17. You have free access to this content
    B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents

    Arthritis & Rheumatism

    Volume 56, Issue 5, May 2007, Pages: 1417–1423, Axel Finckh, Adrian Ciurea, Laure Brulhart, Diego Kyburz, Burkhard Möller, Silvia Dehler, Sylvie Revaz, Jean Dudler, Cem Gabay and Physicians of the Swiss Clinical Quality Management Program for Rheumatoid Arthritis

    Version of Record online : 27 APR 2007, DOI: 10.1002/art.22520

  18. Abdominal phlegmons in Crohn's disease: Outcomes following antitumor necrosis factor therapy

    Inflammatory Bowel Diseases

    Volume 18, Issue 4, April 2012, Pages: 691–696, Garret Cullen, Byron Vaughn, Awais Ahmed, Mark A. Peppercorn, Martin P. Smith, Alan C. Moss and Adam S. Cheifetz

    Version of Record online : 6 JUN 2011, DOI: 10.1002/ibd.21783

  19. You have free access to this content
    Practical application of anti-TNF therapy for luminal Crohn's disease

    Inflammatory Bowel Diseases

    Volume 17, Issue 11, November 2011, Pages: 2366–2391, Michael A. Kamm, Siew C. Ng, Peter De Cruz, Patrick Allen and Stephen B. Hanauer

    Version of Record online : 18 FEB 2011, DOI: 10.1002/ibd.21655

  20. You have free access to this content
    IBD Clinical

    Journal of Gastroenterology and Hepatology

    Volume 28, Issue S2, October 2013, Pages: 82–111,

    Version of Record online : 10 SEP 2013, DOI: 10.1111/jgh.12365_6